Harriët investigates the impact of diet & nutrition and the gut microbiome on human health and physiology, specifically metabolic health, appetite regulation and stress-related disorders throughout life. She uses mechanistic and translational studies, bridging basic and clinical aspects of neuroscience and nutrition. Harriët has established a targeted pharmaceutical approach to identify novel functional bacterial strains and their metabolites as modulators of the gut-brain axis, and to fast-track the most promising strains as effective biotherapeutics against obesity and stress.
Harriët Schellekens, MSc, PhD
Principal Investigator, Lecturer
University College Cork/ APC Microbiome Ireland